MDMA-Assisted Psychotherapy Research & Clinical Insights | Journey Clinical
Psychedelic-Assisted Psychotherapy Research
Explore the latest research on Psychedelic-Assisted Psychotherapy:
- 2024 MDMA | Effects of MDMA-assisted therapy for PTSD on self-experience
- 2024 MDMA | Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
- 2024 MDMA | Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
- 2023 MDMA | Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
- 2023 MDMA | MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
- 2022 | Psychedelic integration: An analysis of the concept and its practice
- 2022 | Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems
- 2022 | Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default
- 2022 | Antidepressants are not associated with improved quality of life in the long run, study finds
- 2021 | MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
- 2021 | Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
- 2020 | Making Bad Trips Good: How users of psychedelics narratively transform challenging trips into valuable experiences